BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Braithwaite T, Calvert M, Gray A, Pesudovs K, Denniston AK. The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice. Patient Relat Outcome Meas 2019;10:9-24. [PMID: 30774489 DOI: 10.2147/PROM.S162802] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Stolk-Vos AC, Kasigar H, Nijmeijer KJ, Missotten TO, Busschbach JJ, van de Klundert JJ, Kranenburg LW. Outcomes in patients with chronic uveitis: which factors matter to patients? A qualitative study. BMC Ophthalmol 2020;20:125. [PMID: 32228570 DOI: 10.1186/s12886-020-01388-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kastner A, King AJ. Advanced glaucoma at diagnosis: current perspectives. Eye (Lond) 2020;34:116-28. [PMID: 31740802 DOI: 10.1038/s41433-019-0637-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen BS, Galus T, Archer S, Tadić V, Horton M, Pesudovs K, Braithwaite T, Yu-Wai-Man P. Capturing the experiences of patients with inherited optic neuropathies: a systematic review of patient-reported outcome measures (PROMs) and qualitative studies. Graefes Arch Clin Exp Ophthalmol 2022. [PMID: 35024911 DOI: 10.1007/s00417-021-05534-0] [Reference Citation Analysis]
4 Robertson AO, Tadić V, Rahi JS. Attitudes, experiences, and preferences of ophthalmic professionals regarding routine use of patient-reported outcome measures in clinical practice. PLoS One 2020;15:e0243563. [PMID: 33275625 DOI: 10.1371/journal.pone.0243563] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Taylor DJ, Jones L, Edwards L, Crabb DP. Patient-reported outcome measures in ophthalmology: too difficult to read? BMJ Open Ophthalmol 2021;6:e000693. [PMID: 34212114 DOI: 10.1136/bmjophth-2020-000693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Gazzard G, Kolko M, Iester M, Crabb DP; Educational Club of Ocular Surface and Glaucoma (ECOS-G) Members. A Scoping Review of Quality of Life Questionnaires in Glaucoma Patients. J Glaucoma 2021;30:732-43. [PMID: 34049352 DOI: 10.1097/IJG.0000000000001889] [Reference Citation Analysis]
7 Petzold A, Braithwaite T, van Oosten BW, Balk L, Martinez-Lapiscina EH, Wheeler R, Wiegerinck N, Waters C, Plant GT. Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence. J Neurol Neurosurg Psychiatry 2020;91:9-14. [PMID: 31740484 DOI: 10.1136/jnnp-2019-321653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
8 Schlenker MB, Minotti SC, Kabanovski A, Lim M, D'Silva C, Ma J, Reid R, Ahmed IIK. Catquest-9SF questionnaire and eCAPS: Validation in a Canadian population. PLoS One 2020;15:e0237788. [PMID: 32976522 DOI: 10.1371/journal.pone.0237788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Gao R, Chen S, Yan S, Lu T, Chen H, Feng Q, Wang Q, Sun Y, Huang J, Khadka J. Psychometric Assessment of the Chinese Version of the Indian Vision Functioning Questionnaire Based on the Method of Successive Dichotomizations. Transl Vis Sci Technol 2021;10:8. [PMID: 34100924 DOI: 10.1167/tvst.10.7.8] [Reference Citation Analysis]
10 Assi L, Rosman L, Chamseddine F, Ibrahim P, Sabbagh H, Congdon N, Evans J, Ramke J, Kuper H, Burton MJ, Ehrlich JR, Swenor BK. Eye health and quality of life: an umbrella review protocol. BMJ Open 2020;10:e037648. [PMID: 32868362 DOI: 10.1136/bmjopen-2020-037648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dunbar GE, Titus M, Stein JD, Meijome TE, Mian SI, Woodward MA. Patient-Reported Outcomes After Corneal Transplantation. Cornea 2021;40:1316-21. [PMID: 33758138 DOI: 10.1097/ICO.0000000000002690] [Reference Citation Analysis]
12 VanNasdale DA, Jones-Jordan LA, Hurley MS, Shelton ER, Robich ML, Crews JE. Association between Vision Impairment and Physical Quality of Life Assessed Using National Surveillance Data. Optom Vis Sci 2021;98:1063-9. [PMID: 34570033 DOI: 10.1097/OPX.0000000000001773] [Reference Citation Analysis]
13 Babac A, Damm K, Graf von der Schulenburg JM. Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review. Health Econ Rev 2019;9:34. [PMID: 31832812 DOI: 10.1186/s13561-019-0251-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Janic A, Bowden S, Levy S, Stinson J, Dimaras H. Patient-reported outcome measures for retinoblastoma: a scoping review. J Patient Rep Outcomes 2020;4:66. [PMID: 32770435 DOI: 10.1186/s41687-020-00232-7] [Reference Citation Analysis]
15 Recchioni A, Aiyegbusi OL, Cruz-Rivera S, Rauz S, Slade A. A systematic review assessing the quality of patient reported outcomes measures in dry eye diseases. PLoS One 2021;16:e0253857. [PMID: 34370748 DOI: 10.1371/journal.pone.0253857] [Reference Citation Analysis]
16 Braithwaite T, Davis N, Galloway J. Cochrane corner: why we still don't know whether anti-TNF biologic therapies impact uveitic macular oedema. Eye (Lond) 2019;33:1830-2. [PMID: 31189993 DOI: 10.1038/s41433-019-0481-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Braithwaite T, Wiegerinck N, Petzold A, Denniston A. Vision Loss from Atypical Optic Neuritis: Patient and Physician Perspectives. Ophthalmol Ther 2020;9:215-20. [PMID: 32200476 DOI: 10.1007/s40123-020-00247-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Schultz NM, Braunack-Mayer L, Schwartz J, Gaspar L. The Patient Experience: Symptoms and Impact of Dry Age-Related Macular Degeneration. Ophthalmol Ther 2021;10:151-64. [PMID: 33512689 DOI: 10.1007/s40123-020-00325-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lacy GD, Abalem MF, Musch DC, Jayasundera KT. Patient-reported outcome measures in inherited retinal degeneration gene therapy trials. Ophthalmic Genet 2020;41:1-6. [PMID: 32100594 DOI: 10.1080/13816810.2020.1731836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Madheswaran G, Ramesh SV, Pardhan S, Sapkota R, Raman R. Impact of living with a bilateral central vision loss due to geographic atrophy-qualitative study. BMJ Open 2021;11:e047861. [PMID: 34326049 DOI: 10.1136/bmjopen-2020-047861] [Reference Citation Analysis]
21 Balparda K, Herrera-Chalarca T, Silva-Quintero LA, Torres-Soto SA, Vanegas-Ramírez CM. Development and Validation of the "Keratoconus End-Points Assessment Questionnaire" (KEPAQ), a Disease-Specific Instrument for Evaluating Subjective Emotional Distress and Visual Function Through Rasch Analysis. Clin Ophthalmol 2020;14:1287-96. [PMID: 32494119 DOI: 10.2147/OPTH.S254370] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]